BioNTech is continuing with COVID shot in step with WHO steering – ET HealthWorld

BioNTech is continuing with COVID shot in step with WHO steering – ET HealthWorld

Frankfurt: Germany’s BioNTech stated it was on monitor to introduce a COVID-19 shot by the early fall within the northern hemisphere that’s tailored to at the moment dominant virus variants in step with suggestions by the World Well being Organisation.

BioNTech was concentrating on regulatory approval by the top of the summer season to permit for a seasonal vaccination marketing campaign to begin in early autumn, CEO and co-founder Ugur Sahin advised shareholders on the biotech agency’s annual normal assembly on Thursday.

BioNTech is collaborating on the vaccine with Pfizer in markets outdoors of larger China. A WHO advisory group final week advisable that this 12 months’s COVID-19 booster pictures be up to date to focus on one of many at the moment dominant XBB variants.

BioNTech/Pfizer’s new formulation would purpose to supply antibody responses to the XBB.1.5 or XBB.1.16 variants, as most well-liked by the WHO, Sahin stated, including that the companions would introduce a ready-to-use single dose, a change from the multi-dose vials that had been normal through the pandemic.

Moderna and Novavax have additionally been engaged on variations of their respective vaccines concentrating on XBB.1.5 and different at the moment circulating strains.

  • Printed On Might 26, 2023 at 12:06 PM IST

Be part of the neighborhood of 2M+ trade professionals

Subscribe to our e-newsletter to get newest insights & evaluation.

Obtain ETHealthworld App

  • Get Realtime updates
  • Save your favorite articles

Scan to obtain App

Supply hyperlink


Please enter your comment!
Please enter your name here